Epstein-Barr Virus EBV Has Targetable Sites Monoclonal Antibodies Can Attack To Provide Protection Against the Infection

Medicine & Technology Oct 28, 2022

An experiment on monoclonal antibodies targeting different sites of the Epstein-Barr virus (EBV) provided nearly complete protection against the infection and lymphoma in mice. Read the article to learn more details.

Development of Respiratory Syncytial Virus (RSV) Vaccine and Monoclonal Antibodies Underway

Aug 13, 2022

A new study describes various vaccine and antibody strategies for the respiratory syncytial virus (RSV) that could help in preventing the disease in at-risk groups. Read the article to learn more.

New Antiviral Drug Receives FDA Emergency Use Authorization For Mild Covid-19 Cases

Nov 10, 2020

Bamlanivimab may soon get FDA approval as a treatment for mild and moderate patients with coronavirus.

What Are Monoclonal Antibodies and Why Are They a Bridge to The Coronavirus Vaccine?

Jul 18, 2020

Scientists believe that monoclonal antibodies can help fight the coronavirus amidst the absence of the ultimate desired treatment, a viable vaccine. Learn what these antibodies are and how they work.